采取行动的时间:关于预防性过敏原标签 (PAL) 的最新情况
Paul J Turner1, Antonio Bognanni2,3,4, Stefania Arasi5
1National Heart & Lung Institute, Imperial College London, London, UK.
The World Allergy Organization journal
|October 9, 2024
概括
预防性过敏原标签 (PAL) 在全球范围内应用不一致,给食物过敏的消费者带来了挑战. 本审查审查了当前的做法和国际努力,以建立一个规范的框架,无意的过敏原存在 (UAP) 的PAL.
科学领域:
- 食品科学 食品科学 食品科学
- 过敏原管理 过敏原管理
- 监管事务 监管事务
背景情况:
- 预防性过敏原标签 (PAL) 传达了食品中意外存在过敏原 (UAP) 的风险.
- 世界过敏组织 (WAO) 强调,不一致和不受监管的PAL使用会降低消费者的效用.
- 世卫组织,粮农组织和食品标签法典委员会 (CCFL) 等国际机构正在处理PAL法规.
研究的目的:
- 总结有关PAL的当前数据,以告知系统应用.
- 支持制定针对过敏原标签的全球食品标准.
- 确定一个受监管的PAL框架的挑战和前景.
主要方法:
- 一个非系统的文献审查和专家咨询.
- 对有关过敏原标签和UAP的全球立法进行分析.
- 审查国际努力合理化PAL.
主要成果:
- 虽然许多国家监管过敏原成分声明,但很少有针对UAP.
- 不受监管的PAL会给过敏患者带来解释困难和不便.
- 现有的PAL标准化的努力取得了不尽相同的成功.
结论:
- 有望为PAL制定有效的,均的全球立法.
- 不确定性的领域可能会阻碍国际关于受监管的PAL框架的协议.
- CCFL对粮农组织/世卫组织专家商的考虑是PAL监管的关键时刻.
相关概念视频
Allergic Reactions
26.7K
Overview
26.7K
Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Allergic Reactions: Anaphylaxis
293
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
293
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
386
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
386
Investigation of Disease Outbreaks
79
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
79


